These days, the most important health challenge in the world is the outbreak of novel coronavirus (COVID-
19) infection. In December 2019, this viral disease originated as human-to-human transmission (HHT) in
China's Wuhan city and then epidemically spread around the globe [1]. Based on the WHO data, HHT
happens with close contact through sneezing and producing the respiratory droplets of infected individuals.
There are two possible transmission routs for COVID-19: (i) settling these droplets in the mouth or nasal
mucosa and lungs of people with inhaled air, and (ii) touching the disease-ridden surfaces or infected objects
and subsequently touching hands to the mouth, nose, or eyes [2]. Due to the convenient ways to transmit
viral infection, the aggressive prevalence of COVID-19 pneumonia, and its extensive social and economic
impacts, there is an urgent need to explore health management tactics for slowing down the transmission
of COVID-19 and decreasing the related-illness and death rate. It has been proven that this viral infection
has a more pronounced effect on the elderly and patients with underlying diseases (e.g., hypertension,
diabetes mellitus, cardiovascular diseases (CVDs), etc.) [3] Pregnant women are one of the most critical
population groups with a need to take additional precautions against the Covid-19 outbreak as a high risk
of vertical transmission of COVID-19 in the late third trimester has been reported [4,5]. Besides, the
presence of gestational diabetes mellitus (GDM) and preeclampsia in pregnancy may significantly weaken
the immune system and increase the risk of COVID-19 infection. In the recent decade, there has been a
profound demand for utilizing the in vitro fertilization (IVF) procedure among infertile couples. Studies
have shown that the risk of developing GDM and preeclampsia in women treated with IVF is much greater
than with women who conceived naturally [6,7]. Therefore, there is a higher risk of Accepted
ManuscriptCOVID-19 infection in women undergoing IVF. The prenatal anxiety, depression, and stress
are also considered as prevalent public health issues in pregnant women. These psychological reactions can
result in adverse birth outcomes such as miscarriage, preterm birth, low birth weight, and fetal death. Under
the COVID-19 outbreak, stressor anxiety-related concerns of mothers about their health and the health of
their babies are growing exponentially. In nulliparous pregnant women, the adverse mood symptoms
accompanied by childbirth fear may have irreversible effects on mother and child health. As a result, a set
of health management practices in the event of COVID-19 outbreak must be adopted not only during late
pregnancy but also during the first 3 months partu
